"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher ...

Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center ...

A study from MUSC Hollings Cancer Center shows a 62% drop in cervical cancer deaths among women under 25, attributed to HPV ...

The cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improve when ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

A new meta-analysis of studies involving more than 14 million people published in the Journal of Infection shows that ...

In order to one day eliminate cervical cancer, the World Health Organization has set out a global strategy: 90 percent of girls to be vaccinated by the age of 15; 70 percent of women screened by the ...

This interesting study presents valuable information on how human cytomegalovirus (HCMV) infection disrupts the activity of the TEAD1 transcription factor, leading to widespread chromatin alterations.

And yet, unlike most other cancers, almost all these cases and deaths can be averted. We have powerful vaccines that can ...

According to a report, nine types of Human papillomavirus (HPV) are accountable for almost 98.4 per cent of total cervical ...

Researchers found a reduction in cervical cancer mortality in women under the age of 25, which is likely due to the introduction of the HPV vaccine.